AAAAAA
Results: 1-25/35
Authors:
Crook, MA
Hally, V
Panteli, JV
Citation: Ma. Crook et al., The importance of the refeeding syndrome, NUTRITION, 17(7-8), 2001, pp. 632-637
Authors:
Crook, MA
Citation: Ma. Crook, Organic-metal toxicity and total parenteral nutrition, NUTRITION, 17(7-8), 2001, pp. 683-683
Authors:
Crook, MA
Steger, A
Citation: Ma. Crook et A. Steger, Abnormal liver function tests in a patient fed with total parenteral nutrition and treated with octreotide, NUTRITION, 17(2), 2001, pp. 152-154
Authors:
Crook, MA
Pickup, JC
Lumb, PJ
Georgino, F
Webb, DJ
Fuller, JH
Citation: Ma. Crook et al., Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study (vol 24, pg 316, 2001), DIABET CARE, 24(5), 2001, pp. 973-973
Authors:
Crook, MA
Pickup, JC
Lumb, PJ
Georgino, F
Webb, DJ
Fuller, JH
Citation: Ma. Crook et al., Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes - The EURODIAB Complications Study, DIABET CARE, 24(2), 2001, pp. 316-322
Authors:
Wierzbicki, AS
Crook, MA
Reynolds, TM
Mikhailidis, DP
Citation: As. Wierzbicki et al., Measurement of atherosclerosis progression, LANCET, 358(9278), 2001, pp. 329-330
Authors:
Stratton, PD
Lumb, PJ
Paganga, G
Crook, MA
Ferro, A
Citation: Pd. Stratton et al., Influence of sialic acid content of low-density lipoprotein particles on endothelium-dependent vasorelaxation in rabbit aorta, ATHEROSCLER, 154(2), 2001, pp. 285-290
Authors:
Wierzbicki, AS
Lumb, PJ
Chik, G
Crook, MA
Citation: As. Wierzbicki et al., Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia, AM J CARD, 87(3), 2001, pp. 338
Authors:
Wierzbicki, AS
Lambert-Hammill, M
Junadi, E
Lumb, PJ
Crook, MA
Citation: As. Wierzbicki et al., Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familiar and polygenic hypercholesterolaemia, J CARD RISK, 7(6), 2000, pp. 431-434
Authors:
Wierzbicki, AS
Reynolds, TM
Gill, K
Alg, S
Crook, MA
Citation: As. Wierzbicki et al., A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease, J CARD RISK, 7(1), 2000, pp. 63-71
Authors:
Crook, MA
Citation: Ma. Crook, Lipid clearance and total parenteral nutrition: The importance of monitoring plasma lipids, NUTRITION, 16(9), 2000, pp. 774-775
Authors:
Wierzbicki, AS
Lambert-Hammill, M
Lumb, PJ
Crook, MA
Citation: As. Wierzbicki et al., Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia, HYPERTENSIO, 36(5), 2000, pp. 808-812
Authors:
Crook, MA
Khandhadia, S
Lumb, P
Ridha, A
Hussain, A
Citation: Ma. Crook et al., No difference in serum sialic acid in Type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy, DIABET RE C, 47(2), 2000, pp. 147-150
Authors:
Wierzbicki, AS
Reynolds, TM
Crook, MA
Jackson, G
Citation: As. Wierzbicki et al., Are drugs interchangeable?, LANCET, 355(9200), 2000, pp. 317-317
Authors:
Crook, MA
Citation: Ma. Crook, Skin tags and the atherogenic lipid profile, J CLIN PATH, 53(11), 2000, pp. 873-874
Authors:
Crook, MA
Lynas, J
Wray, R
Citation: Ma. Crook et al., A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate, J CLIN PATH, 53(10), 2000, pp. 796-797
Authors:
Crook, MA
Citation: Ma. Crook, Chemical pathology: what has changed?, J CLIN PATH, 53(1), 2000, pp. 6-6
Authors:
Crook, MA
Citation: Ma. Crook, Near patient testing and pathology in the new millennium, J CLIN PATH, 53(1), 2000, pp. 27-30
Authors:
Wierzbicki, AS
Crook, MA
Nair, DR
Mikhailidis, DP
Winder, AF
Citation: As. Wierzbicki et al., More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia, ATHEROSCLER, 148(1), 2000, pp. 204-204
Authors:
Crook, MA
Scott, DA
Stapleton, JA
Palmer, RM
Wilson, RF
Sutherland, G
Citation: Ma. Crook et al., Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation, EUR J CL IN, 30(10), 2000, pp. 861-865
Authors:
Wierzbicki, AS
Crook, MA
Mikhailidis, DP
Winder, AF
Citation: As. Wierzbicki et al., Natural statins and stroke, CIRCULATION, 101(3), 2000, pp. E45-E45
Authors:
Wierzbicki, AS
Lumb, PJ
Chik, G
Crook, MA
Citation: As. Wierzbicki et al., High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia, AM J CARD, 86(5), 2000, pp. 547
Authors:
Wierzbicki, AS
Lumb, PJ
Semra, Y
Chik, G
Christ, ER
Crook, MA
Citation: As. Wierzbicki et al., Atorvastatin compared with simvastatin-based therapies in the management of severe familiar hyperlipidaemias, QJM-MON J A, 92(7), 1999, pp. 387-394
Authors:
Wierzbicki, AS
Lumb, PJ
Chik, G
Crook, MA
Citation: As. Wierzbicki et al., Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia, INT J CL PR, 53(8), 1999, pp. 609-611
Authors:
Crook, MA
Ch'ng, SI
Lumb, P
Citation: Ma. Crook et al., Serum apolipoprotein H and its relationship to lipids and other apolipoproteins in normal human men and women, BL COAG FIB, 10(4), 1999, pp. 197-200